NovoCure Limited
Status: Publicly traded
Direct answer
NovoCure Limited is publicly traded on NASDAQ under the ticker NVCR.
NovoCure Limited operates as an oncology enterprise specializing in the development, manufacturing, and global commercialization of its proprietary Tumor Treating Fields (TTFields) technology. These innovative devices are engineered to treat solid tumor cancers, with the company's market presence spanning the United States, Europe, the Middle East, Africa, Japan, and Greater China. The company's commercialized...
Can you invest in NovoCure Limited?
Yes. NovoCure Limited trades publicly on NASDAQ as NVCR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NovoCure Limited
Detailed equity research is provided by MarketSnap.